🇺🇸 FDA
Pipeline program

tasimelteon

VP-VEC-162-1108

Phase 1 small_molecule completed

Quick answer

tasimelteon for Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals Netherlands B.V.
Indication
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials